Elsevier

Peptides

Volume 7, Supplement 1, 1986, Pages 101-107
Peptides

Receptors
Effector mechanisms of peptides of the VIP family

https://doi.org/10.1016/0196-9781(86)90171-3Get rights and content

Abstract

The present review is focused on the exocrine pancreas and liver where the only known effector mechanism of VIP is the activation of adenylate cyclase in plasma membranes. A two-state model of activation-deactivation of the enzyme visualizes the participation of VIP receptors and Ns, the guanyl nucleotide stimulatory protein of adenylate cyclase. In the rat pancreas, VIP and GRF receptors are indistinguishable and disulfide bridges influence their functional integrity. The antagonism of VIP and somatostatin perhaps requires, at the adenylate cyclase level, the contribution of Ni, the guanyl nucleotide inhibitory protein. The potentiation of VIP by various stimulants acting on Ca2+ movements may rely on later events, e.g., on a concerted activation of protein kinases. When comparing quantitatively peptide binding to receptors with adenylate cyclase activation, cyclic AMP levels and amylase secretion, a tool is at hand to tailor synthetic agonists and antagonists of VIP, with appropriate changes in the N-terminal moiety of the peptide (a good agonist allows efficient coupling of receptors to the adenylate cyclase system). Apart from stimulussecretion coupling, VIP may influence protein synthesis in the rat pancreas, through the phosphorylation of ribosomal protein S6, and may alter the activity of the endoplasmic reticulum via the phosphorylation of Mr=21 kDa and Mr=25 kDa proteins. In rat liver membranes, high affinity VIP receptors are specifically labelled with 125I-helodermin and are coupled to adenylate cyclase (at variance with low affinity VIP receptors). These receptors are highly responsive to divalent cations and to guanyl nucleotides.

References (42)

  • P. Robberecht et al.

    Effects of His1 modifications on the ability of vasoactive intestinal peptide to stimulate adenylate cyclase from rat and human tissues

    Peptides

    (1984)
  • P. Robberecht et al.

    Immunoreactive helodermin-like peptides in rat: a new class of mammalian neuropeptides related to secretin and VIP

    Biochem Biophys Res Commun

    (1985)
  • M. Svoboda et al.

    Distinct effects of the C-terminal octapeptide of cholecystokinin and of a cholera toxin pretreatment on the kinetics of rat pancreatic adenylate cyclase activity

    Biochim Biophys Acta

    (1981)
  • M. Svoboda et al.

    The differential detergent solubilization of adenylate cyclase and polypeptide ADP-ribosylated with cholera toxin suggests an excess of G/F protein relative to adenylate cyclase in rat pancreatic plasma membranes

    FEBS Lett

    (1981)
  • A. Vandermeers et al.

    Phosphorylation of 3 particulate proteins in rat pancreatic acini in response to vasoactive intestinal peptide (VIP), secretin and cholecystokinin (CCK-8)

    Peptides

    (1984)
  • A. Vandermeers et al.

    Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom

    FEBS Lett

    (1984)
  • M. Waelbroeck et al.

    Binding of vasoactive intestinal peptide (VIP) and VIP-stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments

    Biochim Biophys Acta

    (1981)
  • J. Christophe et al.

    Gastrointestinal hormone-receptor interactions in the pancreas

  • J. Christophe et al.

    Effect of VIP on the exocrine pancreas

  • J. Christophe et al.

    Determining steps in the regulatory GTPase cycle of rat pancreatic adenylate cyclase

  • J. Christophe et al.

    Receptors for secretin, helodermin, VIP (vasoactive intestinal peptide), PHI, and GRF (growth hormone releasing factor) in the rat pancreas

  • Cited by (0)

    Paper presented at Second International Symposium on Vasoactive Intestinal Peptide (VIP) and Related Peptides (Cap d'Agde, June 18–22, 1985).

    View full text